Ken Lim, M.D., Ph.D., M.Phil., F.A.S.N. is an American Physician-Scientist and Nephrologist in the Division of Nephrology & Hypertension at Indiana University School of Medicine (IUSM). Prior to joining the faculty at IUSM in 2020, he spent over 10 years at Harvard Medical School and affiliated major teaching hospitals, later becoming Attending Physician at The Massachusetts General Hospital and a faculty member at Harvard Medical School. He is a graduate of The University of Cambridge (Christ’s College) and The University of Warwick in England.
Dr. Lim is a Clinical and Translational Scientist and leads a research group that focuses on the development and delivery of definitive trials in the area of cardiovascular disease in patients with kidney failure, and the development of advanced therapeutics. A major theme of his research group is the introduction of Cardiopulmonary Exercise Testing (CPET) into the field of cardio-nephrology, and to create advanced peptide therapeutics inspired by nature. A vision of his group is to be a strategic launching pad for next generation innovators, bioinspirationalists and clinical researchers who are global thinkers at the forefront of expanding the boundaries of this exciting field. Dr. Lim has a special interest in bioinnovation, healthcare entrepreneurship, and translational strategies for taking biological discoveries into early phase exploratory trials.
In his clinical role, he maintains an active clinical practice. He has deployed to regions around the world to provide leading medical care and strategic principles to help meet critical needs of victims of humanitarian crises, such as war, poverty and natural disasters.
Contact email: firstname.lastname@example.org